Atıf İçin Kopyala
KÜÇÜK M., CELEN M. C., YAMASAN B. E., Olgar Y., ÖZDEMİR S.
CARDIOVASCULAR DRUGS AND THERAPY, cilt.29, sa.5, ss.419-424, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
29
Sayı:
5
-
Basım Tarihi:
2015
-
Doi Numarası:
10.1007/s10557-015-6617-2
-
Dergi Adı:
CARDIOVASCULAR DRUGS AND THERAPY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.419-424
-
Anahtar Kelimeler:
Ticagrelor, Ventricular myocytes, L-type Ca2+ currents, Contractility, Action potential, P2Y(12) ANTAGONIST AZD6140, RECEPTOR ANTAGONIST, POTASSIUM CURRENTS, P2 RECEPTORS, ADENOSINE, THIENOPYRIMIDINONES, THIENOPYRIDINES, CLOPIDOGREL, GUINEA, SAFETY
-
Akdeniz Üniversitesi Adresli:
Evet
Özet
Antiplatelet therapy has been widely used for management of patients with ischaemic heart diseases or thrombotic events. Experimental studies have shown that ticlopidine and clopidogrel decreased L-type Ca2+ currents (I-CaL), altered action potential (AP) duration and thence exerted negative inotropic effects. In this study we tested if ticagrelor, a non-thienopyridine agent, has any influence on contractile and electrical properties of isolated ventricular myocytes.